Fellow Publications

Publications 

• Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512:  A Randomized Trial of Hyperfractionation vs. Conventional Fractionation in T2N0 Glottic Squamous Cell Carcinoma
  Abstract to be published in ASCO 2023 annual meeting.
• The Effect of Race on Outcomes in Veterans With Hepatocellular Carcinoma at a Single   Center.  Published in Federal Practitioner · Aug 2, 2022
• Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastoma glioblastoma Published in CNS Oncology · Sep 6, 2021
• Antiviral Therapy Improves Hepatocellular Cancer SurvivalAntiviral Therapy Improves Hepatocellular Cancer Survival
  Published in Federal Practitioner · Sep 3, 2021 

Poster presentation 

• Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512:  A Randomized Trial of Hyperfractionation vs. Conventional Fractionation in T2N0 Glottic Squamous Cell Carcinoma
  ASCO 2023 Poster Presentation- June 2, 2023
• Antiviral Therapy Improves Hepatocellular Cancer Survival Antiviral Therapy Improves Hepatocellular Cancer Survival
  National Comprehensive Cancer Network · Mar 17, 2021 

Submitted projects 

• A Systemic Review of Large Cell Neuroendocrine Carcinoma of the Prostate and a Review of Current Literature
  Submitted to Oncology Reviews in Oct 2022
• A case report of pituitary abscess in the setting of recurrent meningitis
  Submitted to BMJ journal in Oct 2022
• Case report:  Inherited Thrombocytopenic Purpura, Upshaw-Schulman Syndrome Mimicking Atypical Hemolytic Uremic Syndrome in Pregnancy. 
  Submitted to BMJ journal

Ongoing project 

• Tissue microarray analysis in African American with lung cancer
• Status of project:  collecting tissue sample, build up database
• Systemic review of primary pulmonary Ewing sarcoma
• Status of project:  working on writing up the manuscripts
• Implementation of a Survivorship Care Plan Program at the Memphis Veteran-Affair Medical Center Oncology Clinic: A Quality Improvement Project
• Status: complete abstract

Publications

• J. Rich, W.C. Jackson. Pain in a man with opioid use disorder who is taking medication-assisted therapy. Consultant. 2021. doi:10.25270/con.2021.06.00002

Poster presentation

• Jessica Rich, DO, Nick Diloreto, MD, Al Weir, MD. Prevalence of recreational and medical cannabis use in veterans and interactions with cancer-directed pharmacologic treatment. UTHSC Cancer Institute 1st Annual Research Day. Memphis, TN. Oral and poster presentations. 12/21

Ongoing projects

• Prevalence of recreational and medical cannabis use in veterans and interactions with cancer-directed pharmacologic treatment
  • Project design, proposal development
  • IRB APPROVED!
  • First data collection planned 5/1/22

Publications

• BMC Cancers; 2022 22:407 : Association of a novel 27-gene immune-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
• Case report BCC review at BMJ final review

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study. Clin Lung Cancer. 2023 Mar;24(2):137-144. doi: 10.1016/j.cllc.2022.11.009. Epub 2022 Dec 5. PMID: 36564297

Ongoing projects

• Working on second cohort of the first project: Association of a novel 27-gene immune-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer. Already collected data on 102 patients. Working on analysis. 
• Racial Disparity Lung cancer screening: 
• Helping Ngan with Tissue Micro Array Project on Lung Cancer 
• Biomarker in CDK4/6 inhibitors manuscript to be submitted soon. Final revisions ongoing. 

Publications

• Reynolds J, Hashimi S, Nguyen N, Weir A, Khattak A. The Effects of Race on Outcomes in Veterans with Hepatocellular Carcinoma. Federal Practitioner. 2022 (submitted)
• Stein MK, Karri S, Reynolds J, et al. Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib. World Journal of Oncology. 2018;9(2):62-65. doi:10.14740/wjon1099w.

Publications

• Breast Cancer in the Elderly: An Observational Study Investigating Compliance of Screening Mammography in an Underserved Community - PubMed (nih.gov) Published in World Journal Oncology Oct 2021

Poster/Abstracts

• Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review | Blood | American Society of Hematology (ashpublications.org) - published in Blood in November 2021
• Prevalence of Recreational and Medical Cannabis Use in Veterans and Interactions with Cancer Directed Pharmacologic Treatment 
  
• SCC of the liver – A Case Report
  
• Adrenal Insufficiency Associated  to Immune Checkpoint Inhibitors: Case series and literature review

Publications

• Harris LJ, Patel K, Martin M. Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma; Int J Mol Sci. 2020 Nov 13;21(22). doi: 10.3390/ijms21228553. Review. PubMed PMID: 33202794; PubMed Central PMCID: PMC7698117. 
• Altahan A, Harris LJ, Porta J, Jain AL, Martin MG. Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma; Anticancer Res. 2020 Oct;40(10):5423-5426. doi: 10.21873/anticanres.14552. PubMed PMID: 32988863. 

Ongoing projects

• Circulating tumor DNA in early stage TNBC, Signatera funding. I've submitted IRB. Dr Vidal is PI.
• Retrospective chart review of adjuvant capecitabine in high-risk TNBC. Manuscript being written by myself and Terrance Jones. Dr Vidal PI.

Submitted

• Harris LJ,  Yedlapati N, Gradowski J, Alnoor F, Khaled Y, Randolph B, Rhea I. When In Doubt, Biopsy: Cardiogenic Shock from Isolated T-Cell Leukemia Relapse in Myocardium; Submitted JACC CardioOncology Jan 2022. 

Publications

• Altahan A, Harris LJ, Porta J, Jain AL, Martin MG. Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma. Anticancer Res. 2020 Oct;40(10):5423-5426. doi: 10.21873/anticanres.14552. PMID: 32988863.

  Case report with Dr. Elsedawy on Castleman’s Disease treated with IL6 inhibitor

Publications

• Singh A, Mencia-Trinchant N, Griffiths E, Swaminathan M, Altahan A, Gupta M, Gravina M, Tajammal R, Faber M, Yan L, Sinha E, Hassane D, Hayes D, Guzman M, Iyer R, Wang E, Thota S “Mutant PPM1D and TP53 driven hematopoiesis populates the hematopoietic compartment in response to Peptide Receptor Radionuclide Therapy” JCO Precision Oncology, 2022 (6)
• Otieno, S, AlTahan, A, Saradari, K, Kaweeta, F, Alnoor F, Johnson, R. “Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria,” Case Reports in Hematology, volume 2021, July 2021. 
• Morris, LK*, Altahan, A*, Gandhi, J, Mays J, Giri U, Fleming M, Martin M “Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.” J Surg Oncol. volume 123, Issue 2, Pages 687− 692, February 2021. (*Equal contribution) 
• Altahan A, Harris LJ, Porta J, Jain A, Martin M “Association between pesticides use and incidence of diffuse large B cell lymphoma (DLBCL)” Anticancer Research, volume 40, number 10, pages 5423-5426, October 2020.  
• Otieno S, Altahan A, Karri S, Kaweeta F, Lands L, and Weir A, "CIN or not: An approach to the evaluation and management of chronic idiopathic neutrophilia," Blood Reviews, published online August 2020. 

Abstracts/Oral Presentations

• Singh A, Mencia-Trinchant N, Griffiths E, Swaminathan M, Altahan A, Gupta M, Gravina M, Tajammal R, Faber M, Yan L, Sinha E, Hassane D, Hayes D, Guzman M, Iyer R, Wang E, Thota S “Mutant PPM1D and TP53 driven hematopoiesis populates the hematopoietic compartment in response to Peptide Receptor Radionuclide Therapy,” The University of Tennessee Health Science Center,  Center for Cancer Research 1st Annual Symposium, Dec 2021 (Best clinical fellow oral presentation award) 

Submissions

• Altahan A and Chandler J "Nasopharyngeal and sinonasal myeloid sarcoma, a rare presentation of a rare disease," manuscript in preparation.

Projects in planning phase

• Use of machine learning in predicting outcomes of patients with malignancies
• Racial disparities in hematologic malignancies

Publications

• “A Systemic Review of Large Cell Neuroendocrine Carcinoma of the Prostate and a Review of Current Literature”
  Advisor: Dr. Ahmed
  Status: Submitted

Ongoing Projects

• VA Lung cancer screening project
• CtDNA use as a prediction tool for treatment response in early stage triple negative breast cancer (Dr. Vidal)

Publications

• A Pedunculated Skin Lesion in a Case of Clear Cell Renal Carcinoma;Monitoring Editor: Alexander Muacevic and John R AdlerMeghana Kesireddy, 1 Amit Correa,2 and Rohit Venkatesan2 PMID: 31497450
• Neoadjuvant Radiation with Concurrent 5-FU Resulting in Complete Pathologic Response in Stage IIIB Squamous Cell Carcinoma of the Urethra.Authors: Krishna H. Suthar, Meghana Kesireddy, Mark Sides, Amit Correa, Aijan Ukudeyva and Rohit VenkatesanDOI: http://dx.doi.org/10.1155/2020/7948538

Ongoing Projects

• Aberration in the EGFR pathway leading to EGFR resistance. This is based on IHC staining on biopsies from lung tissue or metastatic sites.
  Under review by Dr. Hayes 
• IHC staining looking for splice site mutations in the Androgen receptor leading to castrate resistance in prostate cancer.Mentor: Dr. R Narayan
• Analyzing and staining for enzymes that can explain resistance to Enzalutamide in Prostrate cancer Mentor: Dr. R Narayan

Publications

• Steve Biko Otieno, Alaa Altahan, Sarada s Karri, Fnu Kaweeta, Lindsey Lands , Alva, Weir. 
  CIN or not: An approach to the evaluation and management of chronic idiopathic neutrophilia in Blood Review, Article number 100739, PII S0268-960X(20)30089-8 in August 2020 
• Steve Biko Otieno, Alaa Altahan, Fnu Kaweeta,1Saradasri Karri, Fnu Alnoor, and Robert Johnson 
  Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria," Case Reports in Hematology, vol. 2021, Article ID 6619177, 6 pages, 2021 

Publications

• Aurora T, et. al. Successful HPV Vaccination in Adolescents with Sickle Cell Disease Following a Quality Improvement Bundle Intervention. Blood, Volume 138, Supplement 1, 2021, Page 914, ISSN 0006-4971. doi: 10.1182/blood-2021-151461.
• Aurora T et al. Successful use of eculizimab in treatment of thrombotic microangiopathy in pediatric acute SARS-CoV2 infection and multisystem inflammatory syndrome in children’ Haematologica 2022; https://doi.org/wo.3324/haematol.2022.280603

Ongoing Projects

Project Goal:
Implementation of transition to adult program for sickle cell disease in low and middle income countries. Working with two clinics in Brazil – one in Sao Paulo and one in Rio de Janeiro

Aim 1:
Identify evidence-based practices (EBP) for health care transition in SCD at St. Jude Children’s Research Hospital in Memphis, TN

Aim 1 Progress:
Conducted retrospective review of 580 patients who transitioned to adult care through St. Jude. Determined the elements of transition that predicted successful transition. Abstract accepted to ASH 2022. Manuscript currently pending. 

Aim 2: 
Determine facilitators and barriers to implementation of health care transition in Brazil.

Aim 2 Progress:
Conducted 9 surveys and 42 interviews with various stakeholders in Brazil (providers, nurses, patients, families, etc). Preliminary results have been collected, analysis ongoing. 

Aim 3: 
Create transition toolkit to launch in Brazilian clinic

Aim 3 Progress:
Held 2 day meeting in Memphis with all of Brazilian team. Reviewed facilitators and barriers and began working on transition protocol.

Patient-Family and Provider Perspectives Regarding Sickle Cell Care. 
This a collaborative article with Hematology, Palliative Care, and PICU regarding patient and provider attitudes during care of sickle cell patients: primary author

Use of Eculizumab in TMA Secondary to MIS-C in Children with Hematological Conditions
We have submitted this paper to Hematologica for review.

Implementation of Transitional Sickle Cell Care Model in Rio, Brazil
This is my capstone project I will work on for the next 2 years.

Publications

• E. M. Miller et al.1806p Analysis of germline mutations in non-syndromic malignancies with concurrent pathogenic variants in BRCA1,BRCA2, PALB2, ATM, CHEK2,and RAD51C/D. Ann Oncol 2021, 32(supp 5), s1229

Ongoing Projects

• Focused Review article on “Management of Adverse Reactions for BCMA- =Directed Therapy in Relapsed Multiple Myeloma” (Submitted for publication)
• Systemic Review on “Management of Ewing Sarcoma in Lungs, Clinical Challenges and Future perspectives” (Ongoing)
• Lung Cancer Screening outcomes in patient population at VA Medical Center Memphis (Ongoing)
• Efficacy and safety of Azacitidine - Venetoclax combination in African Americans and minority populations – Multicenter study (Submitted IRB)
• Biomarker assessment in CDK4/6 inhibitors treated patients (finalizing manuscript)
• Analysis of germ-line mutations in non-syndromic malignancies with concurrent pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2, and RAD51C/D (Manuscript writing process)

Publications (in fellowship)

• Xinyu von Buttlar. A Patient with Small Cell Lung Cancer (SCLC) and unexplained muscle weakness – a case study. To be published in the first annual publication, Proceedings of PrecisCa. 2023 April. Oral presentation see below. 
• Xinyu von Buttlar. A Patient with stage IV lung adenocarcinoma with high PD-L1 – a case study. To be published in the first annual publication, Proceedings of PrecisCa. 2023 April.

Publications (in residency)

• Xinyu von Buttlar, Joshua E. Reuss, Stephen V. Liu, Chul Kim. EML4-AML rearrangement as a mechanism of resistance to osimertinib in metastatic lung adenocarcinoma: a case report. Accepted for publication in Journal of Thoracic Oncology-Clinical and Research Reports. 2021 April. JTOCRR-D-21-00047R1.
• Srikar Reddy, Xinyu von Buttlar, Daniel Casey. Obstructive shock presenting like ST-elevation myocardial infarction. Accepted for publication in JECCM. 2021 April; manuscript ID: JECCM-20-139.
• Jonna S, Vanderwalde A, Nieva J, Poorman KA, Saul M, von Buttlar X, Hu JY, Liu SV. Effect of prior therapy on tumor mutational burden in NSCLC. Transl Lung Cancer Res. 2021 Mar;10(3):1231-1238.
• Alexandra D’Oto, Jie Fang, Hongjian Jin, Beisi Xu, Shivendra Singh, Anoushka Mullasseril, Victoria Jones, Xinyu von Buttlar, Bailey Cooke, Dongli Hu, Jason Shohet, Andrew J Murphy, Andrew M Davidoff, Jun Yang. KDM6B promotes oncogenic CDK4/6-pRB-E2F pathway via maintaining enhancer activation in high-risk neuroblastoma. Nat Commun. 2021 Dec 10;12(1):7204. doi: 10.1038/s41467-021-27502-2. PMID: 34893606; PMCID: PMC8664842.
• Jamie E. Flerlage, Xinyu von Buttlar, Matthew Krasin, Brandon Triplett, Sue C. Kaste, Monika L. Metzger. Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients. Pediatr Blood Cancer. 2019
  Dec;66(12):e27962.

Oral presentation

• A Patient with Small Cell Lung Cancer (SCLC) and unexplained muscle weakness – a case study. Presented at the PrecisCa's 1st Annual National Fellows Forum held in Miami, Florida. 2023 April.

Ongoing Projects

• Tissue Microarray Analysis for African American with lung cancer. Mentor: Dr. Neil Hayes.
• Changing landscape of PNH management. Invited Review Articles. Mentor: Dr. Swapna Thota.
• Clinical utility of postoperative ctDNA in stage II colorectal cancer. Mentor: Dr. Saurin Chokshi. 
• BESPOKE study of ctDNA guided therapy in colorectal cancer (BESPOKE CRC). Mentor: Dr. Lindsey Lands.

Active projects

• Title– Prevalence of medical and recreational cannabis use and interaction with cancer
  Mentor– Dr Weir
  Your contribution– data collection 
  Present point of progress in completing the project
  Expected date of project completion

Project exploration

• Areas of interest – CDK inhibitor use in breast cancer patients in rural vs urban populations. 
  Mentors – Dr Vidal 
  Plan to initiate project – in the next month 

Ongoing projects

• Tissue microarray analysis in African Americans with lung cancer. Mentor: Dr. Hayes
• Systematic review and metaanalysis of CHOP vs. CHOP plus regimens in PTCL with focus on AITL-Searching literature and refining the question in collaboration with Dr. Hashimi. Mentor: Dr. Hamid
• Marrow Bio-repository project with Dr. Thota and other co-fellows. 

New Project

• Meta-Analysis and review looking at PFS in first line regimens of CHOP + a novel agents, such as HDAC inhibitors, compared with CHOP in AITL. Ongoing - research mentor Hamid, working with Simran Sekhon. 

Case Report - ongoing

• Upshaw Schulman Syndrome – A rare Masquerader of Atypical Hemolytic Syndrome And TTP in pregnancy related thrombotic microangiopathy. 
• Working with Ngan and Kaweeta, stalled after Kaweeta's graduation. Need to re-explore publication options. 

Publication

• Reynolds J, Hashimi S, Nguyen N, Infield J, Weir A, Khattak A. The Effect of Race on Outcomes in Veterans with Hepatocellular Carcinoma at a Single Center. Fed Pract. 2022;39(Suppl 3):S64-S67a. doi:10.12788/fp.0304

Active projects

• Retrospective Case-Control Study of Adjuvant Capecitabine in Triple-Negative Breast Cancer with Moderate to High Residual Cancer Burden Score. Dr. Vidal. 
• Cell therapy project with Dr. Randolph, writing the protocol 
  Biology and Outcomes of Patients with Cancer and/or Blood Diseases. Dr. Thota Consents 
  Analyzing Barriers Leading to Delays In Accessing Hematologic Care: A Survey Study Of Patients With Hematologic Malignancies. Dr. Thota 

QI

• Stream line our effort to decrease time to antibiotics from a fever spike. 

JAK Pseudokinase Domain Variants Highlight nRTK nsSNPs Identified with Next-Generation. IASLC Yokohama, Japan October 2017

Survival Outcomes for Various Treatment Modalities in Early-Stage Grade 3 Follicular Lymphoma (FL3) - a National Cancer Data Base (NCDB) study.  27th Annual Mayo Clinic Hematology/Oncology Reviews August 2017

Adjuvant Chemo in Stage II Colon Cancer.  Surgical Oncology Symposium Memphis, TN  September 2016

Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using next-generation sequencing (NGS). 27th Annual Mayo Clinic Hematology/Oncology Reviews August 2017

Localization of Non-Receptor Tyrosine Kinase (nRTKs) Variants Identified in Solid Tumor Patients with Next-Generation Sequencing (NGS).  27th Annual Mayo Clinic Hematology/Oncology Reviews August 2017

Clinical trial in progress: A phase 1b trial of talimogene laherparepvec (T-VEC) in combination with dabrafenib and trametinib in advanced melanoma with an activating BRAF mutation. Society for Immunotherapy of Cancer (SITC) November 2017

Clinical outcomes of PD-1 inhibition by PD-L1 expression level across malignancies in 204 consecutive patients in a real world oncology setting.  Society for Immunotherapy of Cancer (SITC) November 2017

Mahadevan, D., Johnson, N., Johnson, B., Pandey, P., Chandler, J., Cooke, L.  Novel mutational profiles in relapsed/refractory advanced cancer patients' pre- and post-targeted therapy.  Presentation at Mayo Clinic 7/30/15.

Johnson, B., Giri S., Nunnery S., Wiedower E., Jamy O., Chandler J., Martin MG.  Comorbities drive outcomes for both malignancy and non-malignancy associated hemophagocytic syndromes.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Jamy O., Giri S., Wiedower E., Johnson B., Nunnery S., Martin MG.  Under recognition of hemophagocytic lymphohistiocytosis in US rural non-teaching hospitals.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Qi, W., Morales, C., Cooke, L.S., Johnson, B., Somer, B, Mahadevan, D.  Dual Inhibition of the Androgen Receptor & PI3K/mTOR Pathways has significant anti-tumor activity in Castration-Resistant Prostate Cancer.  Oncotarget. 2015, Dec 8, pg 41976-87.

Giri, S., Chi, M., Johnson, B., Jamy, O., McCormick, D., Martin, M.  Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.  Leuk Res. 2015, Dec.  pg 1342-6. 

Johnson, B. and Johnson, R.  Secondary Hemophagocytic Lymphohistiocytosis (SHLH) in the Context of Newly Diagnosed Philadelphia Positive, CD 20+ B-Cell Acute Lymphoblastic Lymphoma (B-ALL): A Case Report and Brief Review of Literature.  J Cancer Biol Res v3 issue 2  Dec 2015 pg 1061.

E. Wiedower.  Induction of AML with idarubicin, cytarabine, and cladribine.  Presentation at Mayo Clinic Meeting  7/30/2015.

Jamy O., Giri S., Wiedower E., Johnson B., Nunnery S., Martin MG.  Under recognition of hemophagocytic lymphohistiocytosis in US rural non-teaching hospitals.  Presentation ASH - Hematologic Maligancies  7/31/2015.

Johnson, B., Giri S., Nunnery S., Wiedower E., Jamy O., Chandler J., Martin MG.  Comorbities drive outcomes for both malignancy and non-malignancy associated hemophagocytic syndromes.  Presentation ASH - Hematologic Maligancies  7/31/2015.

Wiedower, Giri, Fintel, Prouet, Paulus, Chandler, Martin.  Addition of rituximab to chemotherapy decreased mortality rates of primary surgery for gastric DLBCL without increasing early mortality.  Presentation ASH - Hematologic Maligancies 7/31/2015.

O Jamy, S. Nunnery, E. Wiedower, B. Johnson, G. Yaghmour, M. Martin.  Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States' Rural, Non-Teaching Hospitals.  Leuk Lymphoma epub ahead of print. V 18 issue April 2016 pg 1-3

B. McCullar, M. Pandey, G. Yaghmour, F. Hare, K. Patel, M. Stein, R. Feldman, JC Chandler, MG Martin. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.  Breast Cancer Res Treat. 2016 Jul;158(1):195-202.  June 21, 2016.

Giri S, Chi M, Johnson B, McCormick D, Jamy O, Bhatt VR, Martin MG.  Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.  Leuk Res. 2015 Dec;39(12):1342-6

VanderWalde NA, Chi MT, Hurria A, Galsky MD, Nielsen ME.  Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.  World J Urol. 2016 Jan;34(1):3-11

Smith Giri, MD, Syed Sameer Nasir, MD, Michael Gary Martin MD,  Outcome of Adolescent and young adults with acute myeloid leukemia.  Presentation ASH - Hematologic Maligancies  9/9/2015.

Smith Giri, MD, Syed Sameer Nasir, MD, Michael Gary Martin MD,  Outcome of Adolescent and young adults with acute myeloid leukemia.  Presentation ASH – Annual Meeting  12/5/2015.

Syed Sameer Nasir, MD, Alva B Weir, MD.  ICU Deaths in Advanced Cancer Patients: Reasonable Criteria to Decrease Potentially Inappropriate Admissions and Lack of Benefit of Advance Planning Discussions.  American Journal of Hospice and Palliative Care Medicine.  Dec 2015.

Syed Sameer Nasir, MD; Micheal G Martin MD.  Outcome of Adolescents and Young Adults As Compared to Pediatric Patients with Acute Myeloid and Acute Promyelocytic Leukemia: Real World Data from the SEER Registry.  Presentation at ASCO annual meeting June, 2016.

Syed S Nasir MD; Lee Schwartzberg MD.   Updates on Chemotherapy Induced Nausea and Vomiting.  Journal of Oncology.  May, 2016.

Syed Sameer Nasir, MD.  ICU Deaths in Advanced Cancer Patients: Reasonable Criteria to Decrease Potentially Inappropriate Admissions and Lack of Benefit of Advance Planning Discussions.  TOPS Winner 5/6/2016.